期刊文献+

非体外循环冠状动脉旁路移植术患者手术前后凝血功能的变化 被引量:7

Coagulation Function Changes in Patients Undergoing Off-pump Coronary Artery Bypass Grafting
下载PDF
导出
摘要 目的探讨非体外循环冠状动脉旁路移植术(off-pump coronary artery bypass grafting,OPCAB)患者手术前后凝血功能的变化。方法 2009年12月~2011年3月,选择76例OPCAB,于手术当天清晨及术毕进入恢复室时取静脉血进行血栓弹力图(thromboelastography,TEG)分析,术后血样处理选用含肝素酶的测定杯消除残余肝素对结果的干扰,观察TEG中的R时间,K时间,α角,MA,A30,CL30,LY30等指标的变化情况。结果手术前后K时间和α角差异无显著性(P>0.05),与术前相比,术后R时间、MA、A30和CL30均减小,而LY30增加,差异有显著性(P<0.05)。术后均未出现死亡,无脑卒中和心肌梗死等并发症发生,无二次开胸探查,术后出院顺利。结论 OPCAB患者术后呈高凝状态,且纤溶过程相对亢进。 Objective To analyze coagulation function changes in patients undergoing off-pump coronary artery bypass grafting (OPCAB) through thromboelastography (TEG). Methods From December 2009 to March 2011, 76 patients with OPCAB were selected in our hospital. The first blood sample was taken in the morning before operation, and the second was taken when the patient came back to ICU. We used heparinase-modified TEG assays to eliminate residual heparin. R time, K time, angle α, MA, A30, CL30, LY30 changes were observed in TEG. Results No significant differences were found in K time and angle α before vs. after the surgery (P 〉 0.05). Compared with preoperative results, post-operative R time, MA, A30 and CL30 all decresed while LY 30 increased with significant difference (P 〈 0.05). No death, no complications like stroke and myocardial infarction occurred. No re-exploration for bleeding was required in all cases. Conclusion There is a hypercoagulable state with relative hyperfibrinolysis in patients after OPCAB.
出处 《中国微创外科杂志》 CSCD 2013年第8期710-712,共3页 Chinese Journal of Minimally Invasive Surgery
关键词 非体外循环冠状动脉旁路移植术 凝血功能 血栓弹力图 Off-pump coronary artery bypass grafting Coagulant function Thromboelastography
  • 相关文献

参考文献10

  • 1武恒朝,孙寒松,王现强,马维国,张旌,郑哲,马琼.术前不停用阿司匹林对非体外循环冠状动脉旁路移植术后早期的影响[J].中国循环杂志,2010,25(6):412-415. 被引量:3
  • 2Li Z, Yeo K, Parker J, et al. Off-pump coronary artery bypass graft surgery in California, 2003 to 2005. Am Heart J, 2008 , 156 ( 6 ) : 1095 - 1102.
  • 3Quigley R, Fried D, Pym J, et al. Off-pump coronary artery bypass surgery may produce a hypercoagulable patient. Heart Surg Forum, 2003,6(2) :94 -98.
  • 4Zachary N, Michael H, Michael J, et al. Off-Pump coronary artery bypass leads to a regional hypercoagulable state not detectable using systemic markers. Inovations (Phila) ,2006,1(5) :232 -238.
  • 5Takagi H, Tanabashi T, Kawai N, et al. Off-pump coronary artery bypass sacrifices graft patency: meta-analysis of randomized trials. J Thorac Cardiovasc Surg ,2007,133 (1) : e2 - e3.
  • 6Vallely MP, Bannon PG, Bayfield MS, et al. Quantitative and temporal differences in coagulation, fibrinolysis and platelet activation after on-pump and off-pump coronary artery bypass surgery. Heart Lung Circ , 2009 ,18 ( 2) : 123 - 130.
  • 7Desai PH, Kurian D, Thirumavalavan N , et al. A randomized clinical trial investigating the relationship between aprotinin and hypercoagulability in off-pump coronary snrgery. Anesth Analq, 2009,109 (5) : 1387 - 1394.
  • 8Yachi T, Watanabe G, Tomita S. Activation of coagulation and fibrinolysis after off-pump coronary artery bypass grafting with or without endotracheal general anesthesia. Inovations (Phila) ,2010 ,5 (6) :444 -449.
  • 9Englberger L, Markart P, Eckstein F, et al. Aprotinin reduces blood loss in off-pump coronary artery bypass (OPCAB) surgery. Eur J Cardiothorac Surg,2002,22(4) :545 -551.
  • 10佟鑫,赵斌,刘长江,苏华田,夏添,李艳玲,谢海龙,霍冬艳,孙寒松.自体血液回输在非体外循环下冠状动脉旁路移植术后的应用[J].中国微创外科杂志,2010,10(6):510-511. 被引量:2

二级参考文献23

  • 1孙建良,屠海林,黄冰,周煦燕,陆雅萍,孙平.自体血液回输在急诊创伤性手术中的应用[J].浙江创伤外科,2005,10(6):480-481. 被引量:6
  • 2唐丽英.回收式自体血回输的临床运用[J].当代医学,2008,139:69-69.
  • 3Domen RE.Averse reaction associated with autologous transfusion:evaluation and incidence at a large academic hospital.Transfution,1998,38(3):296.
  • 4Faris PM,Ritter MA,Keating EM,et al.Unwashed filtered shed blood collected after knee and hip arthroplasties.A source of autologous red blood cells.J Bone Joint Surg(Am),1998,73:1169.
  • 5Antithrombotic Tria]ists'Collaboration.Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high-risk patients.Br Med J,2002,324:71-86.
  • 6Mangano DT.For the Multicenter study of perioperative isehemia research group.Aspirin and mortality from coronary bypass surgery.N Engl J Med 2002,347:1309-1317.
  • 7Eagle KA,Guyton RA,Davidoff R,et al.ACC/AHA 2004 guideline update for coronary artery bypass graft surgery:a report of the american college of cardiology/american heart association task force on practice guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).Circulation,2004,110:e340-437.
  • 8Chesebro JH,Fuater V,Elveback LB,et al.Effect of dipyridamole and aspirin on late vein-groft patency after cnronary bypass operations.N Engl J Med,1984,310:209-214.
  • 9Goldman S,Copeland J,Moritz T,et al.Improvement in early saphenous vein graft patency after coronary artery bypass graft surgery with antiplatelet therapy:results of a veterans administration cooperative study.Circulation,1988,77:1324-1332.
  • 10Gavnghan TP,Gebski V,Baron DW.Immediate postoperative aspirin improves graft patency early and late after coronary artery bypass graft surgery.Circulation,1991,83:1526-1533.

共引文献3

同被引文献54

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部